Evidence map›Paper›PMID 27590826›Full record

ArticleJournal of neuroinflammation2016

Metabolic determinants of the immune modulatory function of neural stem cells.

Denise Drago, Veronica Basso, Edoardo Gaude, Giulio Volpe, Luca Peruzzotti-Jametti, Angela Bachi, Giovanna Musco, Annapaola Andolfo, Christian Frezza, Anna Mondino and 1 more

Open access · goldAbstract read
In one paragraph

Article in Journal of neuroinflammation, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Stem Cell Therapies for Progressive Multiple Sclerosis.Frontiers in cell and developmental biology · 2021
    Review
  8. Review
  9. Review
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Denise DragoCNS Repair Unit, Institute of Experimental Neurology (INSPE), Division of Neurosciences, San Raffaele Scientific Institute, 20132, Milan, Italy. drago.denise@hsr.it.
Veronica BassoLymphocyte Activation Unit, San Raffaele Scientific Institute, 20132, Milan, Italy.
Edoardo GaudeMedical Research Council Cancer Unit, Hutchison/MRC Research Centre, Cambridge, CB2 0XZ, UK.
Giulio VolpeDepartment of Clinical Neurosciences, Wellcome Trust-Medical Research Council Stem Cell Institute and National Institute for Health Research Biomedical Research Centre, University of Cambridge, Hills Road, CB2 0HA, Cambridge, UK.
Luca Peruzzotti-JamettiDepartment of Clinical Neurosciences, Wellcome Trust-Medical Research Council Stem Cell Institute and National Institute for Health Research Biomedical Research Centre, University of Cambridge, Hills Road, CB2 0HA, Cambridge, UK.
Angela BachiBiomolecular Mass Spectrometry Unit, Division of Genetics and Cell Biology, San Raffaele Scientific Institute, 20132, Milan, Italy.
Giovanna MuscoBiomolecular NMR Unit, San Raffaele Scientific Institute, 20132, Milan, Italy.
Annapaola AndolfoProMiFa, Protein Microsequencing Facility, San Raffaele Scientific Institute, 20132, Milan, Italy.
Christian FrezzaMedical Research Council Cancer Unit, Hutchison/MRC Research Centre, Cambridge, CB2 0XZ, UK.
Anna MondinoLymphocyte Activation Unit, San Raffaele Scientific Institute, 20132, Milan, Italy.
Stefano PluchinoDepartment of Clinical Neurosciences, Wellcome Trust-Medical Research Council Stem Cell Institute and National Institute for Health Research Biomedical Research Centre, University of Cambridge, Hills Road, CB2 0HA, Cambridge, UK. spp24@cam.ac.uk.
National Institute for Health Research · GBHutchison/MRC Research Centre · GBMedical Research Council · GBSan Raffaele University of Rome · IT

Funding

Medical Research Council MC_PC_12009Medical Research Council MR/K026682/1Wellcome Trust RG79423
6 · The paper itself

Abstract

backgroundNeural stem cells (NSCs) display tissue trophic and immune modulatory therapeutic activities after transplantation in central nervous system disorders. The intercellular interplay between stem cells and target immune cells is increased in NSCs exposed to inflammatory cues. Here, we hypothesize that inflammatory cytokine signalling leads to metabolic reprogramming of NSCs regulating some of their immune modulatory effects.

methodsNSC lines were prepared from the subventricular zone (SVZ) of 7-12-week-old mice. Whole secretome-based screening and analysis of intracellular small metabolites was performed in NSCs exposed to cocktails of either Th1-like (IFN-γ, 500 U/ml; TNF-α, 200 U/ml; IL-1β, 100 U/ml) or Th2-like (IL-4, IL-5 and IL-13; 10 ng/ml) inflammatory cytokines for 16 h in vitro. Isotopologues distribution of arginine and downstream metabolites was assessed by liquid chromatography/mass spectrometry in NSCs incubated with U-(13)C6 L-arginine in the presence or absence of Th1 or Th2 cocktails (Th1 NSCs or Th2 NSCs). The expression of arginase I and II was investigated in vitro in Th1 NSCs and Th2 NSCs and in vivo in the SVZ of mice with experimental autoimmune encephalomyelitis, as prototypical model of Th1 cell-driven brain inflammatory disease. The effects of the inflammatory cytokine signalling were studied in NSC-lymph node cells (LNC) co-cultures by flow cytometry-based analysis of cell proliferation following pan-arginase inhibition with N(ω)-hydroxy-nor-arginine (nor-NOHA).

resultsCytokine-primed NSCs showed significantly higher anti-proliferative effect in co-cultures vs. control NSCs. Metabolomic analysis of intracellular metabolites revealed alteration of arginine metabolism and increased extracellular arginase I activity in cytokine-primed NSCs. Arginase inhibition by nor-NOHA partly rescued the anti-proliferative effects of cytokine-primed NSCs.

conclusionsOur work underlines the use of metabolic profiling as hypothesis-generating tools that helps unravelling how stem cell-mediated mechanisms of tissue restoration become affected by local inflammatory responses. Among different therapeutic candidates, we identify arginase signalling as novel metabolic determinant of the NSC-to-immune system communication.

Indexed as

AnimalsArginaseArginineCell ProliferationCells, CulturedCoculture TechniquesColorimetryCytokinesDisease Models, AnimalEncephalomyelitis, Autoimmune, ExperimentalFemaleImmunologic FactorsLateral VentriclesMetabolomicsMiceNeural Stem CellsArginaseArginineCytokinesImmunologic FactorsArginase IImmune modulationLymph node cellsMetabolomicsNeural stem cells

Identifiers

PMID27590826
PMCPMC5009670
OpenAlexW2517690870

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.